"We are proud that our achievements in revolutionary proprietary technology are being recognized," says Ken Charhut, president and CEO of MindFrame Inc. "Our global mission is to continue leading technology development with more ischemic stroke solutions for our clinicians that allow successful procedural and clinical outcomes for their patients."
The MindFrame Therapy Solutions technology portfolio was recently expanded to include the MindFrame Capture LP 4-mm diameter and multiple shorter-length–sized low profile devices. The MindFrame Capture LP is the first and only device that can be deployed through smaller microcatheters to improve navigation through tortuous vessels. MindFrame LP devices provide clinicians with unprecedented access to thrombus aspiration locally and proximally as a result of the reduced microcatheter size. In addition, the devices offer improved tensile strength and kink resistance for device durability, as well as enhanced trackability for precise placement and control.
MindFrame Capture LP is not approved for sale in the United States.
About MindFrame Inc.
MindFrame Inc. is a pioneer in developing optimized technologies for patients experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions portfolio comprises some of the most advanced device design technology that delivers exceptional rapid flow restoration and clot extraction intended to help clinicians provide improved clinical outcomes for their patients. For more information about the breakthrough MindFrame Capture LP state-of-the-art technologies, visit www.MindFrameInc.com.
Posted by Sean Fenske, Editor-in-Chief, MDT